Abbvie Stock News & Updates
[WKN: A1J84E | Symbol: ABBV]
US Markets Closed on Friday – Diplomatic Collapse and Hormuz Blockade in Middle East Poker – Toy Story 5 Saves Disney’s Box Office – L3Harris Delivers New President Jet in Record Time – AbbVie Nears Billion-Dollar Acquisition of Apogee Therapeutics – SpaceX Receives Catastrophic ESG Rating Before IPO – Microsoft CEO Nadella Calls for Radical AI Strategy Shift – ASML Under Pressure Due to Renewed US Sanction Concerns
The US stock markets remained closed on Friday, June 19, 2026, due to the Juneteenth National Independence...
Strong Market Jump in the US – Inflation Lower Than Expected – Hope for Three Rate Cuts – Trump Increases Pressure on Powell – Labor Market Report to Continue – Circle Raises USDC Circulation by 90% - Perplexity Offers $34.5 Billion for Chrome – CoreWeave Drops Despite Strong Revenue Increase – CAVA Significantly Misses Store Growth – Rigetti Presents Roadmap for 100 Qubit Systems – AbbVie Invests in US Production – eToro Benefits From Trading Boom
On Tuesday, August 12, 2025, the major US stock exchanges made a strong rebound. The Dow Jones gained...
Drug Revenues Higher Than Expected! AbbVie Soars and Raises Earnings Forecast for 2025!
The pharmaceutical company AbbVie (ABBV) announced its business figures for the 1st quarter of 2025 on...
Pharmaceutical Stocks are Gaining Momentum: The Defensive Winners of 2025
In times of increased market volatility, pharmaceutical stocks are experiencing a remarkable comeback....
Financially Strong Year-End: AbbVie Exceeds Expectations
AbbVie is a global biopharmaceutical company specializing in the research and development of drugs in...
- ‹
- 1
- ›